Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
RCUS
$17.43
-1.91%
RCUS
· Arcus Biosciences, Inc.
$17.43
-0.34 (-1.91%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.51B
Shares
143.99M
Volume · Nov 13
1.14M
Avg daily vol (3M)
1.84M
All webcasts
Earnings call · FY2025 Q2
Arcus Biosciences, Inc. (RCUS) Q2 2025 Earnings Call
Revenue
$160.00M
+310.3% YoY
Diluted EPS
$0.00
Net income
$0
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2025.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
GAAP revenue
full year 2025
|
$225M – $235M | GAAP | $247M above |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2025 · complete as-filed document